期刊文献+

产AmpC酶肺炎克雷伯菌的耐药性及基因型研究 被引量:4

A study on resistance and genotypes of AmpC beta-lactamase producing Klebsiella pneumoniae in Anhui province
下载PDF
导出
摘要 目的了解安徽地区产AmpC酶肺炎克雷伯菌的基因型特征及耐药性。方法对180株肺炎克雷伯菌进行头孢西丁纸片法初筛,三维实验筛选高产AmpC酶菌,PCR扩增、测序和BLAST比对分析以确定AmpC基因型,琼脂稀释法检测耐药性。结果产AmpC酶菌株有21株(11.67%),其中DHA型17株,EBC型4株。3株EBC型为新基因(gene bank登录号为FJ237366,FJ237367,FJ237368);药敏显示产酶株除对亚胺培南与美罗培南敏感外,对其他抗菌药物均有不同程度的耐药。结论安徽地区产AmpC酶的肺炎克雷伯菌以DHA型为主,同时存在EBC型突变株。高产AmpC酶菌的感染推荐使用碳青霉烯类抗生素治疗。 Objective To identify the plasmid-mediated AmpC gene and to investigate its prevalence in Klebsiella pneumoniae strains isolated in Anhui Province.Methods The AmpC-producing isolates were chosen by cefoxitin and identified by the three-dimensional test.The plasmid-mediated AmpCβ-lactamases were detected by multiplex PCR.The PCR products were directly sequenced and analyzed. M-H agar dilution method was used to determine MIC of 17 antimicrobial agents against the AmpC positive isolates.Results Of the 180 strains,21(11.67%) proved to be plasmid-mediated highly productive AmpC by DNA sequence test.Blast results indicated that the positive AmpC group was composed of 17 strains which carried DHA type and 4 strains which carried EBC type.DNA sequence analysis revealed three novel AmpC genotypes(GenBank accession:FJ237366,FJ237367,and FJ237368).All AmpC positive isolates exhibited high resistance to the third or fourth generation cephalosporins,aminoglycosides,and quinolones.But all of them were susceptible to imipenem and meropenem.Conclusions The plasmid-mediated AmpCβ-lactamases were found in Klebsiella pneumoniae strains isolated in Anhui Province and DHA type was dominant.Moreover,three novel AmpC genotypes were identified.The carbapenems are recommended to treat the AmpC-producing isolates.
出处 《临床检验杂志》 CAS CSCD 北大核心 2009年第6期453-455,共3页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(30772286) 安徽省自然科学基金(070413110)
关键词 AMPC酶 肺炎克雷伯菌 耐药性 基因型 AmpCβ-lactamase Klebsiella pneumoniae resistance genotype
  • 相关文献

参考文献10

  • 1Philippon A,Arlet G,Jaeoby G A. Plasmid-determined AmpC-type β-lactamases [J]. Antimicrob Agents Chemother,2002,46( 1 ) : 1-11.
  • 2Clinical and Laboratory Standards Institute/NCCLS. Performance standards for antimicrobial susceptibility testing [S]. Sixteenth informational supplement. CLSI/NCCLS document M100-S17. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2007, 27(1) :1-163.
  • 3Perez F, Nancy H. Detection of plasmid -mediated AmpC lactamase genes in clinical isolates by using multiplex PCR [J]. J Clin Microbiol,2002,40(6) : 2153-2162.
  • 4陈燕,叶英,王谦,程君,王迎迎,李家斌.产质粒介导AmpC酶的肺炎克雷伯菌耐药性和基因型研究[J].临床检验杂志,2008,26(1):10-12. 被引量:6
  • 5邵海枫,崔蕾蕾,赵晓智,王锦娜,王卫萍.多重PCR技术检测肺炎克雷伯菌中质粒介导的AmpC酶基因[J].临床检验杂志,2005,23(6):414-417. 被引量:15
  • 6Coudron P E. Moland E S, Thomson K S. Occurrence and detection of AmpC β -lactamases among Escherichia coli, Klebsiella pneumoniae ,and Proteus mirabilis isolates at a Veterans' Medical Center [J]. J Clin Microbiol.2000.38(5) : 1791-1796.
  • 7彭敬红,孙自鏞,周有利,吕军.肺炎克雷伯菌质粒AmpC酶的基因型研究[J].中华医院感染学杂志,2007,17(9):1072-1075. 被引量:2
  • 8Barnaud G, Arlet G, Verdet C, et aL Salmonella enteritidis : AmpC plasmid-mediated inducible β-lactamase ( DHA -1 ) with an ampR gene from Morganella morganii [ J]. Antimicrob Agents Chemother, 1998,42(9) :2352-2358.
  • 9管希周,刘又宁.质粒介导的AmpC酶研究进展[J].中华医院感染学杂志,2004,14(6):713-716. 被引量:21
  • 10Babini G S, Danel F, Munro S D, et al. Unusual tazobactam-sensitive AmpC β-lactamase from two Escherichia coli isolates[J]. J Antimicrob Chemother, 1998,41 ( 1 ) : 115 -118.

二级参考文献24

共引文献38

同被引文献34

  • 1王煜,李振华.质粒介导AmpC酶的研究进展[J].国外医学(呼吸系统分册),2005,25(11):854-857. 被引量:5
  • 2沈定树,周雪艳,袁远,徐玖飞,陈慧红,夏东,齐娟飞,陈东.肠杆菌诱导型AmpC酶对第三代和第四代头孢菌素的影响[J].中国微生态学杂志,2006,18(5):384-385. 被引量:9
  • 3喻华,张春平,刘华,颜英俊,黄文方,周忠华,黄湘宁.多重耐药的铜绿假单胞菌产β-内酰胺酶的检测及耐药性研究[J].世界感染杂志,2006,6(6):526-528. 被引量:9
  • 4陈淑贞(综述),钱元恕(审校).AmpC酶的分类、检测与抑制策略[J].国际检验医学杂志,2007,28(1):75-77. 被引量:5
  • 5Bush K, Jacoby G A. Updated functional classification of β lactamases [J]. Ant microb Agents Chermother, 2010,54(3) : 969-976.
  • 6Juan C, Macifi M D, Gutiérrez O, et al. Molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in pseudomonas aeruginosa clinical strains[J]. Antimicrob Agents Chemother,2005,49(ll): 4733-4738.
  • 7Bauvois C, Ibuka A S, Celso A, etal. Kinetic properties of four plasmid-mediated ampC β-lactamases [J]. Antimicrob Agents Chemother, 2005,49(10) :4240-4246.
  • 8Suh B, Bae I K, Kim J,et al. Outbreak of meropenem-resistant serratia marcescens comediated by chromosomal ampC β- lactamase overproduction and outer membrane protein loss[J]. Antimicrob Agents Chemother,2010,54(12) :5057-5061.
  • 9El-Sharif A, Elkhatib WF, Ashour HM. Nosocamial infections in leukemic andsolid-tumor cancer patients distribution, out- come and microbial spectrum of anaerobes[J]. Fut Microbiol, 2012, 7(12). 1423 1429.
  • 10Kamboj M, Son C, Cantu S, et al. Hospital-onset clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant a C31C network report[J]. Infect Control Hosp Epidemiol, 2012, 33(11): 1162-1165.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部